Does Our Body Age Gradually or in Sudden Waves?

The study suggests that human aging may occur in distinct biological phases rather than as a slow, continuous process. Around midlife and again later in adulthood, multiple biological systems appear to undergo coordinated changes that may increase susceptibility to chronic disease. The analysis showed that biological aging does not appear to progress at a constant pace. Instead, many biological markers changed in a non-linear manner, with the most pronounced transitions occurring around the ages of 44 and 60 years. These coordinated changes involved multiple physiological systems, including lipid metabolism, immune regulation, cardiovascular function, kidney function, and the body's ability to metabolise alcohol and caffeine.

Importantly, these age ranges represent population-level transitions rather than fixed biological milestones for every individual. The findings reinforce the concept that biological age and chronological age are not the same, and that different physiological systems may age at different rates.

The researchers also observed that individuals with insulin resistance exhibited distinct molecular aging patterns compared with insulin-sensitive participants. This finding suggests that metabolic health may influence not only the risk of chronic disease but also the biological pathways through which aging progresses.

Together, these results support the concept that biological aging is dynamic, highly individual, and shaped by the interaction of multiple biological systems. They also strengthen the emerging view that biological age may become a more meaningful indicator of health than chronological age when assessing future disease risk and planning personalised preventive strategies.

Rather than viewing aging as a single, uniform process, this study suggests that biological aging may occur in distinct phases and may be modified by an individual's metabolic health. Identifying these transitions with early diagnostics could help optimise the timing of preventive interventions and improve personalised longevity strategies.

For clinicians, this study reinforces two important principles. First, chronological age alone does not fully reflect biological aging, as individuals may age through different biological pathways and at different rates. Second, maintaining good metabolic health—including preventing or treating insulin resistance—may influence not only the risk of diabetes and cardiovascular disease but also the biological processes associated with aging.

The findings also highlight the importance of timely preventive assessment, particularly during midlife, when biological aging may accelerate in many individuals. Comprehensive preventive diagnostics—including cardiovascular risk assessment, metabolic screening, body composition analysis and lifestyle evaluation—may be especially valuable before these biological transition periods, allowing earlier intervention before clinical disease develops.

Although further validation is needed before these findings can be incorporated into routine clinical practice, they support a shift from age-based medicine towards biology-based prevention, where prevention and monitoring are increasingly guided by an individual's biological health rather than chronological age alone.